Management of diabetic small-fiber neuropathy with combination L-methylfolate, methylcobalamin, and pyridoxal 5′-phosphate

Reviews in Neurological Diseases

Volumn 8, Issue 1-2, 2011, Pages 39-47

  Jacobs, Allen M ^a   Cheng, Dunlei ^b  

^a JACOBS ENGINEERING   (United States)

^b BAYLOR HEALTH CARE SYSTEM   (United States)

Author keywords

Diabetic peripheral neuropathy; Epidermal nerve fiber density; Folate; Methylcobalamin; Pyridoxal 5 phosphate

Indexed keywords

FOLIC ACID DERIVATIVE; FOLIC ACID METHYL ESTER; MECOBALAMIN; PYRIDOXAL 5 PHOSPHATE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DENSITY; DIABETIC PERIPHERAL NEUROPATHY; DRUG EFFICACY; DYSESTHESIA; EPIDERMAL NERVE FIBER DENSITY; FEMALE; FOLLOW UP; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARESTHESIA; PERIPHERAL NEUROPATHY; PUNCH BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DRUG COMBINATIONS; EPIDERMIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE FIBERS; PARESTHESIA; SKIN; VITAMIN B 12;

EID: 82555200904     PISSN: 15452913     EISSN: None     Source Type: Journal    
DOI: 10.3909/rind0267     Document Type: Article

References (52)

1. National Diabetes Information Clearinghouse. National Diabetes Statistics, 2007. National Institute of Diabetes and Digestive and Kidney Diseases. http://diabetes.niddk.nih.gov/dm/pubs/statistics/#complications. Accessed February 4, 2011.
2. Kramer HH, Rolke R, Bickel A, Birklein F. Thermal thresholds predict painfulness of diabetic neuropathies. Diabetes Care. 2004;27:2386-2391. (Pubitemid 39281390)
3. Polydefkis M, Hauer P, Sheth S, et al. The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain. 2004;127:1606-1615. (Pubitemid 38899413)
4. Vlčková-Moravcová E, Bednařik J, Dušek L, et al. Diagnostic validity of epidermal nerve fiber densities in painful sensory neuropathies. Muscle Nerve. 2008;37:50-61.
5. Lacomis D. Small-fiber neuropathy. Muscle Nerve. 2002;26:173-188. (Pubitemid 34832799)
6. Shun CT, Chang YC, Wu HP, et al. Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain. 2004;127:1593-1605.
7. Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropathies. A statement by the American Diabetes Association. Diabetes Care. 2005;28:956-962. (Pubitemid 40434506)
8. Frykberg RG, Lavery LA, Pham H, et al. Role of neuropathy and high foot pressures in diabetic foot ulceration. Diabetes Care. 1998;21:1714-1719. (Pubitemid 28449813)
9. Argoff CE, Backonja MM, Belgrade MJ, et al. Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain. Mayo Clin Proc. 2006;81(4 Suppl):S12-S25.
10. Frykberg RG, Zgoni T, Armstrong DG, et al. Diabetic foot disorders. A clinical practice guideline (2006 revision). J Foot Ankle Surg. 2006;45(5 Suppl):S1-S66. (Pubitemid 46187108)
11. Veves A, Akbari CM, Primavera J, et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes. 1998;47:457-463. (Pubitemid 28104210)
12. van Etten RW, de Koning EJ, Verhaar MC, et al. Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by an acute administration of folate. Diabetologia. 2002;45:1004-1010.
13. Verhaar MC, Stroes E, Rabelink TJ. Folates and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2002;22:6-11.
14. Yaqub BA, Siddique A, Sulimani R. Effects of methyl-cobalamine on diabetic neuropathy. Clin Neurol Neurosurg. 1992;94:105-122.
15. Watanabe T, Kaji R, Oka N, et al. Ultra-high dose methylcobalamin promotes nerve regeneration in experimental acrylamide neuropathy. J Neurol Sci. 1994;122:140-143. (Pubitemid 24097261)
16. McCann VJ, Davis RE. Serum pyridoxal concentration in patients with diabetic neuropathy. Aust N Z J Med. 1978;8:259-261. (Pubitemid 9087475)
17. Quattrini C, Tavakoli M, Jeziorska M, et al. Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes. 2007;56:2148-2154. (Pubitemid 47195833)
18. Holland NR, Crawford TO, Hauer P, et al. Smallfiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol. 1998;44:47-59. (Pubitemid 28323654)
19. Sumner CJ, Sheth S, Griffin JW, et al. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology. 2003;60:108-111. (Pubitemid 36070653)
20. Lauria G, Cornblath DR, Johansson O. EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol. 2005;12:747-758. (Pubitemid 41495131)
21. Walker MJ Jr, Morris LM, Cheng D. Improvement of cutaneous sensitivity in diabetic peripheral neuropathy with combination L-methylfolate, methylcobalamin, and pyridoxal 5′-phosphate. Rev Neurol Dis. 2010;7:132-139.
22. Sheehan P. An overview of peripheral neuropathy in diabetes. Vasc Dis Manag. 2009;6:68-71.
23. Mangoni AA, Sherwood RA, Asonganyi B, et al. Short-term folic acid supplementation enhances endothelial function in patients with type 2 diabetes. Am J Hypertens. 2005;18:220-226. (Pubitemid 40332552)
24. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-820. (Pubitemid 34000785)
25. King RH. The role of glycation in the pathogenesis of diabetic polyneuropathy. Mol Pathol. 2001;54:400-408. (Pubitemid 34025255)
26. Schwentker A, Billiar TR. Nitric oxide and wound repair. Surg Clin North Am. 2003;83:521-530. (Pubitemid 36687711)
27. Chen RJ, Zheng YL, Xu LS. Clinical trials on effects of methylcobalamin in the treatment of diabetic neuropathy. Chinese J Clin Rehabil. 2002;6:1280-1281.
28. Boykin JV Jr, Baylis C. Homocysteine - a stealth mediator of impaired wound healing: a preliminary study. Wound. 2006;18:1-12.
29. De Sousa EA, Hays AP, Chin RL, et al. Characteristics of patients with sensory neuropathy diagnosed with abnormal small nerve fibres on skin biopsy. J Neurol Neurosurg Psychiatry. 2006;77:983-985. (Pubitemid 44174092)
30. Wendelschafer-Crabb G, Kennedy WR, Walk D. Morphological features of nerves in skin biopsies. J Neurol Sci. 2006;242:15-21.
31. Ambrosch A, Dierkes J, Lobmann R, et al. Relation between homocysteinaemia and diabetic neuropathy in patients with type 2 diabetes mellitus. Diabet Med. 2001;18:185-192. (Pubitemid 32397855)
32. Bruce SG, Young TK. Prevalence and risk factors for neuropathy in a Canadian First Nation community. Diabetes Care. 2008;31:1837-1841.
33. Cohen JA, Jeffers BW, Stabler S, et al. Increasing homocysteine levels and diabetic autonomic neuropathy. Auton Neurosci. 2001;87:268-273. (Pubitemid 32178126)
34. Venn BJ, Green TJ, Moser R, Mann JI. Comparison of the effect of low-dose supplementation with L-5-methyltetrahydrofolate or folic acid on plasma homocysteine: a randomized placebo-controlled study. Am J Clin Nutr. 2003;77:658-662. (Pubitemid 36258576)
35. Welch GN, Loscalzo J. Homocysteine and atherothrombosis patients. N Engl J Med. 1998;338:1042-1050.
36. van Guldener C. Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering? Nephrol Dial Transplant. 2006;21:1161-1166.
37. Willems FF, Boers GH, Blom HJ, et al. Pharmacokinetic study on the utilisation of 5-methyltetrahydrofolate and folic acid in patients with coronary artery disease. Br J Pharmacol. 2004;141:825-830. (Pubitemid 38446183)
38. Food and Drug Administration (FDA). Frequently Asked Questions about Medical Foods. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Food Safety and Applied Nutrition, May 2007. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/ GuidanceDocuments/MedicalFoods/ucm054048.htm. Accessed February 4, 2011.
39. Verhaar MC, Wever RM, Kastelein JJ, et al. 5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation. 1998;97:237-241. (Pubitemid 28067307)
40. Romerio SC, Linder L, Nyfeler J, et al. Acute hyperhomocysteinemia decreases NO bioavailability in healthy adults. Atherosclerosis. 2004;176:337-344. (Pubitemid 39369524)
41. Li G. [Effect of methylcobalamin on diabetic neuropathies. Beijing Methycobal Clinical Trial Collaborative Group.] Zhonghua Nei Ke Za Zhi. 1999;38:14-17.
42. Devathasan G, Teo WL, Mylvaganam A. Methylcobalamin (CH3-B12; methylcobal) in chronic diabetic neuropathy. Clin Trials J. 1986;23:130-140.
43. Metanx [package insert]. Covington, LA: Pamlab, LLC; 2009.
44. Beiswenger KK, Calcutt NA, Mizisin AP. Epidermal nerve fiber quantification in the assessment of diabetic neuropathy. Acta Histochem. 2008;110:351-362.
45. McCarthy BG, Hsieh ST, Stocks A, et al. Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurol (Tokyo). 1995;45:1848-1855. (Pubitemid 27122956)
46. Wang L, Hilliges M, Jernberg T, et al. Protein gene product 9.5-immunoreactive nerve fibres and cells in human skin. Cell Tissue Res. 1990;261:25-33. (Pubitemid 20205948)
47. Periquet MI, Novak V, Collins MP, et al. Painful neuropathy: prospective evaluation using skin biopsy. Neurology. 1999;53:1641-1647. (Pubitemid 29530333)
48. Ebenezer GJ, Hauer P, Gibbons C, et al. Assessment of the epidermal nerve fibers: a new diagnostic and predictive tool for peripheral neuropathies. J Neuropathol Exp Neurol. 2007;66:1059-1073. (Pubitemid 350294656)
49. Holland NR, Stocks A, Hauer P, et al. Intraepidermal nerve fiber density in patients with painful sensory neuropathy. Neurology. 1997;48:708-711. (Pubitemid 27120111)
50. Hermann DN, Griffin JW, Hauer P, et al. Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology. 1999;53:1934-1940.
51. Lauria G, Devigili G. Skin biopsy as a diagnostic tool in peripheral neuropathy. Nature Clin Pract. 2007;3:546-557. (Pubitemid 47528029)
52. Devigili G, Tugnoli V, Penza P, et al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain. 2008;131:1912-1925. (Pubitemid 351957452)